Cidara Therapeutics Inc
F:20D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cidara Therapeutics Inc
F:20D
|
US |
|
A
|
Agilent Technologies Inc
XMUN:AG8
|
US |
|
S
|
StoneCo Ltd
F:0Q0
|
KY |
|
CEL-SCI Corp
F:LSRM
|
US |
|
Relief Therapeutics Holding SA
OTC:RLFTY
|
CH |
|
S
|
StoneCo Ltd
XBER:0Q0
|
KY |
|
Trulieve Cannabis Corp
NYSE:TRLV
|
US |
|
N
|
Nevada Lithium Resources Inc
F:87K
|
CA |
Intrinsic Value
The intrinsic value for
Cidara Therapeutics Inc (20D) under the Base Case is hidden
EUR.
Compared with the current market price of 9.56 EUR, the stock appears hidden
.
20D looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 20D usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Cidara Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Cidara Therapeutics Inc
Earnings Waterfall
Cidara Therapeutics Inc
The intrinsic value for
Cidara Therapeutics Inc (20D) under the Base Case is hidden EUR.
Compared with the current market price of 9.56 EUR, the stock appears hidden.